Newest first. 5.2k questions across 107 tags.
What I am working with: 99.1% · a C18 column · ecnoglutide. I would like help reading this properly rather than being told what conclusion to reach. I have the full…
What I am working with: Janoshik · a GLP-1 receptor agonist. This is a procedural question rather than a theoretical one, and I would like the procedure rather than…
What I am working with: SURPASS-3 · tirzepatide. I would like help reading this properly rather than being told what conclusion to reach. I have the full report…
The particulars: orforglipron · fourteen days. I have worked this out and I would like someone to find the error, because I suspect there is one. My working so far,…
Stated plainly: a 27G needle · cagrilintide · 6.67 mg/mL. Both of these get recommended confidently by different people, which suggests neither is obviously right. My…
This came up because two published schedules for the same agent differ. I would like help reading this properly rather than being told what conclusion to reach. I…
Details up front: 98.2% · orforglipron · MKM. I would rather over-plan the first cycle and simplify later. I am prepared to do the work if someone can tell me which…
I have three data points across nine months, which I hope is enough to see a trend. I suspect the usual explanation for this is wrong, or at least incomplete. I am…
What I have: 0.5 mg · six weeks · injection-site erythema. I suspect the usual explanation for this is wrong, or at least incomplete. I am aware this may have a…
Details up front: racemisation · a C8 column. I suspect the usual explanation for this is wrong, or at least incomplete. I am aware this may have a boring answer. I…
The case in front of me: twelve weeks · retatrutide. I would rather be corrected now than propagate something wrong. I am specifically not interested in a…
Setup, so nobody has to ask: batch certificate · ERP. This is presented as though it settles something, and I am not convinced it does. I have two documents that…
Conditions: JEEP · Shanghai ERP Biotechnology. I have used one of these for a while and I am considering switching, which requires a reason. What I care about is…
I would like to know what to measure as much as what to do. I want to know whether there is evidence behind this or only repetition. I have checked the obvious…
Conditions: a wine cooler · tirzepatide. I want to decide this in advance so that I am not deciding it under pressure later. Assume I will follow the plan I write…
Concretely: TFC · oral semaglutide. The figures are clear enough; the question is what they mean and what they do not. I can supply the numbers if the specifics…
Conditions: 68 kg · 1,400 kcal. I want the working, not the result — I need to be able to redo it with different numbers. I care about the precision as well as the…
The case in front of me: survodutide · minus 20 °C. I am trying to do this correctly the first time rather than learn it by getting it wrong. I have already made one…
The particulars: GL Biochem · Homopeptide · Spain. I am trying to choose between two options that are usually discussed as though only one exists. I am not optimising…
This is my second independent submission on material from the same supplier. I have the document in front of me and I can read the numbers. What I cannot do is…
I have reached a weight I am happy with on tirzepatide 12.5 mg and I do not want to keep losing. Cost is a factor and so is the fact that I would rather take less of…
The specifics, since they change the answer: fibrillation · ecnoglutide · 40 °C. I understand the observation; what I do not understand is the mechanism behind it. I…
For reference: VendorInvestigate · 96.4%. Something has gone wrong and I would like to know how badly before I decide what to do. Nothing else in the setup changed,…
Stated plainly: cystatin C · ecnoglutide. I understand the observation; what I do not understand is the mechanism behind it. I have read the two review articles that…